Blood pressure variability: Clarity for clinical practice

Hypertension

Volumn 56, Issue 2, 2010, Pages 179-181

  Dolan, Eamon ^a   O'Brien, Eoin ^b  

^a Royal College of Surgeons in Ireland   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE PLUS HYDROCHLOROTHIAZIDE PLUS RESERPINE; PERINDOPRIL; PLACEBO; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; RENIN INHIBITOR; THIAZIDE DIURETIC AGENT;

BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG INDUSTRY; EDITORIAL; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; VARIATION INDEPENDENT OF MEAN; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; OBSERVER VARIATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; OBSERVER VARIATION;

EID: 77955494217     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.154708     Document Type: Editorial

References (14)

1. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895-905.
2. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, Poulter NR, Sever PS, on behalf of the ASCOT-BPLA and MRC Trial Investigators. Effects of/3 blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469-480.
3. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375:938-948.
4. Webb AJS, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375:906-915.
5. Poulter NR, Wedel H, Dahlof B, Sever PS, Beevers DG, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, Pocock S, for the ASCOT investigators. Role of BP and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-BP Lowering Arm (ASCOT-BPLA). Lancet. 2005;366:907-913
6. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus. Arch Intern Med. 2005;165:1410-1419.
7. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target damage in hypertension. Hypertension. 1987;5:93-98.
8. Schillaci G, Parati G. Determinants of blood pressure variability in youth: at the roots of hypertension. J Hypertens. 2010;28:660-664.
9. Kikuya M, Ohkubo T, Metoki H, Asayama K, Hara A, Obara T, Inoue R, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama Study. Hypertension. 2008;52:1045-1050.
10. Brickman AM, Reitz C, Luchsinger JA, Manly JJ, Schupf N, Muraskin J, DeCarli C, Brown TR, Mayeux R. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol. 2010;67:564-569.
11. Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Bjorklund-Bodegård K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Wang J, Ibsen H, O'Brien E, Staessen JA, on behalf of the International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010;55:1049-1057.
12. Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens. 1998;16:1685-1691.
13. O'Brien E. Clinical developments in hypertension management. Irish Medical Times. 2010:44(suppl 13);viii.
14. Black HR. Triple fixed-dose combination therapy: back to the past. Hypertension. 2009;54:19-22.